SI2797945T1 - 2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hidroksiprop-1-il)-4-metoksi-3-(fenil sulfonilmetil)tetrahidrofuran-2-il)acetaldehidni derivati in posptopek za njihovo pripravo - Google Patents

2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hidroksiprop-1-il)-4-metoksi-3-(fenil sulfonilmetil)tetrahidrofuran-2-il)acetaldehidni derivati in posptopek za njihovo pripravo

Info

Publication number
SI2797945T1
SI2797945T1 SI201230582A SI201230582A SI2797945T1 SI 2797945 T1 SI2797945 T1 SI 2797945T1 SI 201230582 A SI201230582 A SI 201230582A SI 201230582 A SI201230582 A SI 201230582A SI 2797945 T1 SI2797945 T1 SI 2797945T1
Authority
SI
Slovenia
Prior art keywords
phenylsulfonylmethyl
hydroxyprop
tetrahydrofuran
methoxy
amino
Prior art date
Application number
SI201230582A
Other languages
English (en)
Slovenian (sl)
Inventor
Fabio E.S. Souza
Alena Rudolph
Ming Pan
Boris Gorin
Dino Alberico
Original Assignee
Alphora Research Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alphora Research Inc. filed Critical Alphora Research Inc.
Publication of SI2797945T1 publication Critical patent/SI2797945T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI201230582A 2011-12-29 2012-12-24 2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hidroksiprop-1-il)-4-metoksi-3-(fenil sulfonilmetil)tetrahidrofuran-2-il)acetaldehidni derivati in posptopek za njihovo pripravo SI2797945T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161581164P 2011-12-29 2011-12-29
EP12863099.3A EP2797945B1 (en) 2011-12-29 2012-12-24 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation
PCT/CA2012/050939 WO2013097042A1 (en) 2011-12-29 2012-12-24 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
SI2797945T1 true SI2797945T1 (sl) 2016-07-29

Family

ID=48696142

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201230582A SI2797945T1 (sl) 2011-12-29 2012-12-24 2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hidroksiprop-1-il)-4-metoksi-3-(fenil sulfonilmetil)tetrahidrofuran-2-il)acetaldehidni derivati in posptopek za njihovo pripravo

Country Status (9)

Country Link
US (1) US9062020B2 (OSRAM)
EP (1) EP2797945B1 (OSRAM)
JP (1) JP6300030B2 (OSRAM)
CN (1) CN104080793B (OSRAM)
AU (1) AU2012363334B2 (OSRAM)
CA (1) CA2860446C (OSRAM)
IN (1) IN2014MN01521A (OSRAM)
SI (1) SI2797945T1 (OSRAM)
WO (1) WO2013097042A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2857385A1 (en) 2011-11-30 2013-06-06 Alphora Research Inc. Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
US9174956B2 (en) 2011-12-16 2015-11-03 Alphora Research Inc. Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof
US9278979B2 (en) 2012-03-30 2016-03-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
TW201617326A (zh) 2014-03-06 2016-05-16 Alphora研發股份有限公司 (s)-1-((2r,3r,4s,5s)-5-烯丙-3-甲氧-4-(對甲苯磺醯甲基)四氫呋喃-2-基)-3-氨基丙-2-醇之結晶衍生物
EP3160970A4 (en) 2014-06-30 2017-12-27 President and Fellows of Harvard College Synthesis of halichondrin analogs and uses thereof
US10147463B2 (en) 2014-12-10 2018-12-04 Nxp Usa, Inc. Video processing unit and method of buffering a source video stream
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MA45280B1 (fr) 2016-03-02 2021-08-31 Eisai R&D Man Co Ltd Conjugués anticorps-médicament à base d'éribuline et leurs procédés d'utilisation
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
KR102836514B1 (ko) 2017-04-05 2025-07-22 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 마크로시클릭 화합물 및 그의 용도
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
ES2974243T3 (es) 2017-11-15 2024-06-26 Harvard College Compuestos macrocíclicos y usos de los mismos

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
ATE191712T1 (de) 1993-07-09 2000-04-15 Theramex Neue strukturelle vitamin d derivate
HU227912B1 (en) 1998-06-17 2012-05-29 Eisai R & D Man Co Halichondrin analogs and methods of their use and preparation
US7001982B2 (en) 2003-03-31 2006-02-21 Council Of Scientific And Industrial Research Non-natural C-linked carbo-β-peptides with robust secondary structures
PL2522663T3 (pl) * 2004-06-03 2015-08-31 Eisai R&D Man Co Ltd Produkty pośrednie do otrzymywania halichondryny B
CN109180615A (zh) * 2004-06-03 2019-01-11 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
CN105801599A (zh) 2008-04-04 2016-07-27 卫材R&D管理有限公司 软海绵素b类似物
CA2857385A1 (en) 2011-11-30 2013-06-06 Alphora Research Inc. Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
US9174956B2 (en) 2011-12-16 2015-11-03 Alphora Research Inc. Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof
US9278979B2 (en) 2012-03-30 2016-03-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
AU2014268086A1 (en) 2013-05-15 2015-11-05 Alphora Research Inc. 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof

Also Published As

Publication number Publication date
WO2013097042A1 (en) 2013-07-04
AU2012363334A1 (en) 2014-08-21
AU2012363334B2 (en) 2017-02-02
JP2015503525A (ja) 2015-02-02
US9062020B2 (en) 2015-06-23
US20150011776A1 (en) 2015-01-08
CA2860446C (en) 2017-01-10
IN2014MN01521A (OSRAM) 2015-05-01
EP2797945A1 (en) 2014-11-05
EP2797945A4 (en) 2015-06-03
CN104080793B (zh) 2017-09-19
EP2797945B1 (en) 2016-03-16
JP6300030B2 (ja) 2018-03-28
CN104080793A (zh) 2014-10-01
CA2860446A1 (en) 2013-07-04

Similar Documents

Publication Publication Date Title
EP2797945A4 (en) 2 - ((2S, 3S, 4R, 5R) -5 - ((S) -3-amino-2-hydroxyprop-1-yl) -4-methoxy-3- (PHENYLSULFONYLMETHYL-) tetrahydrofuran-2-yl) Acetaldehyde derivatives and process for their preparation
SI2707366T1 (sl) Kokristali l-prolina in citronske kisline z (2s,3r,4r,5s,6r)-2-(3-((5-(4-fluorofenil)tiofen-2-il)metil)-4-metil- fenil)-6-(hidroksimetil)tetrahidro-2h-piran-3,4,5-triolom
ZA201209296B (en) 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace)
IL225672B (en) Pharmaceutical composition comprising (2s,3s,4r,5r)-2-(4-amino-5h-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol for inhibiting rna viral polymerase
IL223423A (en) History of 6.5 Dihydro-2 h- [1,4] Oxazin-3-Ill-Amine Used as Inhibitors in Scarlet Cell
LT3683209T (lt) [(5-(3-chlorfenil)-3-hidroksipiridin-2-karbonil)-amino]acto rūgšties gavimo būdas iš 5-((3-chlorfenil)-3-chlor-piridin-2-il)-nitrilo ir 5-((halogenfenil)-3-halogen-piridin-2-il)-nitrilo darinių gavimo būdas
ZA201208198B (en) Picolinamide and pyrimidine-4-carboxamine compounds, process for preparing and pharmaceutical composition comprising the same
SI2796460T1 (sl) Pirolni šestčlenski derivat heteroarilnega obroča, postopek priprave zanj in medicinske uporabe le-tega
EP2687510A4 (en) PROCESS FOR THE PREPARATION OF 2,3-DICHLORPYRIDINE
IL207854A0 (en) Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol
EP2785687A4 (en) PROCESS FOR PREPARING (3R-) 2,4-DI-ABGANBGSGRUPPEN-3-METHYLBUT-1-EN
SG11201405608QA (en) Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal with chloroacetone
FR2949465B1 (fr) Derives chromones, leur procede de preparation et leurs applications therapeutiques
ZA201007611B (en) Process for the preparation of benzo-used heteroaryl sulfamates and crystalline form of n-(((2s)-6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methylsulfamine
IL220376A (en) Polycyclic heterocyclic compounds, process for their preparation, intermediates obtained in said process and pharmaceutical compositions comprising said compounds
SG11201405611SA (en) Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal
IL222351A (en) Process for making derivatives 4,1-diethylene-di (3-pyroline) -tetrone
IL238931A0 (en) Production methods for (1s,4s,5s)-4-bromo-6-oxabicyclo)[3,2,1]octane-7-one
ZA201307451B (en) Acadesine derivatives, products and compositions including same,therapeutic uses thereof and methods for synthesizing same
EP2646416A4 (en) IMPROVED METHOD FOR THE PRODUCTION OF 2-TRIFLUOROMETHYL-5- (1-SUBSTITUTED) ALKYLPYRIDINES
DK2163230T3 (da) Emballage til kirurgiske hjælpemidler, især til præparationstamponer
IL228027A0 (en) Composition of thioamide, method for the production of composition thioamide, method for the production of a derivative of – 3, 1 – aminoethyl – 6 (r6, r4)] acetate [yl –4– dioxan, and its peak for the production of atorvastatin
EP3114112A4 (en) Crystalline derivatives of (s)-1-((2r,3r,4s,5s)-5-allyl-3-methoxy-4-(tosylmethyl)tetrahydrofuran-2-yl)-3-aminopropan-2-ol
EP2522666A4 (en) IMINODERIVATE, METHOD OF MANUFACTURING THEREOF AND INSECTICIDES THEREWITH
EP2699560A4 (en) 5-CARBAMOYL-ADAMANTAN-2-YL AMID DERIVATIVES, PHARMACEUTICALLY ALLOWED SALTS AND METHOD FOR THE PRODUCTION THEREOF